Chen, Yu-Li <br/><br/>
Serous ovarian carcinoma patients with high alpha-folate receptor had reducing survival and cytotoxic chemo-response.  [electronic resource] 

 -  Molecular oncology  Jun 2012 
 - 360-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1878-0261 
<br/><br/><label>Standard No.: </label>10.1016/j.molonc.2011.11.010  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Cystadenocarcinoma, Serous--drug therapy<br/>Female<br/>Flow Cytometry<br/>Folate Receptor 1--metabolism<br/>Humans<br/>Immunoblotting<br/>Immunoprecipitation<br/>In Vitro Techniques<br/>Ovarian Neoplasms--metabolism